Alkermes rises after lifting annual revenue forecast

Alkermes

28/10/2025 11:44

** Shares of drug developer Alkermes ALKS.O up 5.4% at $31.33 premarket

** Co reports Q3 profit of 49 cents/shr vs analysts' average estimate of 67 cents/shr - LSEG data

** Co's quarterly revenue of $394.2 million beats analysts' average expectation of $356.2 million

** ALKS raises annual revenue forecast to $1.43–$1.49 billion from prior $1.34–$1.43 billion

** Up to last close, stock up ~3% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))